Article Information
Published By
History
- Received February 14, 2022
- Accepted June 15, 2022
- Published online September 22, 2022.
Article Versions
- previous version (September 2, 2022 - 06:11).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Author Information
- Xu Zhang1,*,
- Na Qin1,2,*,
- Jingyi Fan3,
- Chang Zhang1,
- Qi Sun1,
- Yayun Gu1,2,
- Meng Zhu1,2,
- Erbao Zhang1,2,
- Juncheng Dai1,2,
- Guangfu Jin1,2,
- Hongxia Ma1,2,4,
- Zhibin Hu1,2 and
- Hongbing Shen1,2,4⇑
- 1Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
- 2Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing 211166, China
- 3Health Management Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215008, China
- 4Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing 100730, China
- Correspondence to: Hongbing Shen, E-mail: hbshen{at}njmu.edu.cn